Helicore Debuts With $65m, Plans For GIP Antagonism In Obesity

 
• By Joseph Haas
  
Versant Ventures backs Helicore to compete in the already busy obesity arena (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Therapy Areas